Profile	GDS4460 / 206466_at
Title	Pimecrolimus and betamethasone valerate effects on lesional skin of actopic dermatitis
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM803586	patient 6, baseline	24.4	44
GSM803589	patient 7, baseline	68.2	61
GSM803592	patient 8, baseline	39.7	51
GSM803595	patient 10, baseline	181.6	77
GSM803598	patient 11, baseline	63.6	61
GSM803601	patient 12, baseline	68.1	61
GSM803604	patient 13, baseline	48.6	57
GSM803607	patient 14, baseline	44.7	54
GSM803610	patient 15, baseline	43.4	54
GSM803613	patient 16, baseline	27	45
GSM803587	patient 6, arm treated with pimecrolimus	34.6	51
GSM803590	patient 7, arm treated with pimecrolimus	36.2	51
GSM803593	patient 8, arm treated with pimecrolimus	68.9	61
GSM803605	patient 13, arm treated with pimecrolimus	46.7	56
GSM803608	patient 14, arm treated with pimecrolimus	41.8	54
GSM803599	patient 11, arm treated with pimecrolimus	64.1	61
GSM803611	patient 15, arm treated with pimecrolimus	70.4	62
GSM803614	patient 16, arm treated with pimecrolimus	61.5	60
GSM803602	patient 12, arm treated with pimecrolimus	30.1	44
GSM803596	patient 10, arm treated with pimecrolimus	117.8	69
GSM803591	patient 8, arm treated with betamethasone	98.9	68
GSM803609	patient 15, arm treated with betamethasone	58.8	57
GSM803597	patient 11, arm treated with betamethasone	79.9	63
GSM803585	patient 6, arm treated with betamethasone	32.9	44
GSM803603	patient 13, arm treated with betamethasone	111.6	69
GSM803612	patient 16, arm treated with betamethasone	46.8	54
GSM803588	patient 7, arm treated with betamethasone	42.3	51
GSM803594	patient 10, arm treated with betamethasone	409.5	88
GSM803600	patient 12, arm treated with betamethasone	32.6	44
GSM803606	patient 14, arm treated with betamethasone	49.6	56